2025 annual financial data
Monopar Therapeutics 2025 Operating margin
Monopar Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -16,704,415 USD and net income was -13,716,894 USD.
Operating cash flow was -12,201,291 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,704,415 USD
- Net income
- -13,716,894 USD
- Operating cash flow
- -12,201,291 USD